Delivery Order SPE2DB22D1052-SPE2DB25FV0AT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,687.56 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on July 31, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a contract ceiling value of $2,852.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,125.04 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,728.92 to AmerisourceBergen Drug Corp for the supply of NEXIUM DR 40 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nexium DR 40 mg capsules (30-count units) valued at $3,942.12, with a firm fixed price and no set-aside designation. The order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90-count supplies of Nexium DR 40 mg capsules with a ceiling value of $2.81K under firm fixed pricing. The award is non-competitive and represents a child contract under AmerisourceBergen's substantial $1 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Nexium DR 40 mg capsules (30-count units) with a ceiling value of $2,323.45. This firm fixed price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was made through competitive procurement with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count packages) with a ceiling value of $2,250.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FV0ATDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $9,251.86. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This delivery order for Nexium, a proton pump inhibitor commonly used to treat gastroesophageal reflux disease, exemplifies the routine pharmaceutical supply operations that AmerisourceBergen executes under its global pharmaceutical support vehicle to sustain military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/9/25 |